NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NeuroIntact, Inc.

NeuroIntact, Inc.

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://neurointact.com/

Last Round

Seed

Dec 11, 2025

Total Funding Raised

$7.15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NeuroIntact, Inc. is a medical device company that develops non-invasive targeted temperature management systems to preserve neurological function in patients with brain injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

targeted temperature managementTTMintranasal coolingneuroprotectionmedical devicebrain coolingneurocritical carecombat casualty caretrauma caredefense techtherapeutic hypothermiaportable medical devicenon-invasive coolingclinical researchmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroIntact, Inc. Comparables

Compare NeuroIntact, Inc. with similar companies based on industry and business-model similarity.

NeuroIntact, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CoolTech Medical
90%
Cryothermic Systems
79%
Neuron Guard
79%

NeuroIntact, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 11, 2025
SeedOct 31, 2024
GrantSep 13, 2024

NeuroIntact, Inc. Investors

Notable investors and investment history

NeuroIntact, Inc. investors
InvestorRounds
TEDCOSeed
Central Texas Angel NetworkSeed
Riptide VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    $6M round led by Riptide Ventures.

  • Jun 22, 2024

    Grew 133% QoQ, from 3 to 7 employees.

NeuroIntact, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuroIntact, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuroIntact, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range8
Year Founded2023
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.